Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Commercial
Patent
Patent
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Patent
Theralase Receives Notice of Acceptance for Multiwavelength Photo Dynamic Therapy from Russian Patent Office
Firstwordpharma News
-
July 16, 2019
Patent
Samsung Bioepis, Genentech settle patent dispute on breast cancer biosimilar: source ...
Patent
HedgePath Pharmaceuticals Announces Notice of Allowability of U.S. Patent Application Regarding Treatment of Prostate Cancer
Patent
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
Patent
Additional Patent Protection for Melflufen Granted in the US Until 2033
Patent
Insmed Granted Additional U.S. Patent For ARIKAYCE (amikacin liposome inhalation suspension),...
Firstwordpharma News
-
April 9, 2019
0
Patent
Oramed Patent Allowed in the U.S. for Oral Exenatide
Biospace News
-
April 4, 2019
0
Patent
Soligenix Receives US Patent for Dusquetide Related Analogs
Biospace News
-
April 4, 2019
0
Patent
SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic...
Firstwordpharma News
-
March 19, 2019
0
Patent
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology
Biospace News
-
March 18, 2019
0
1
2
3
4
Page 1 of 4
- Advertisement -
MOST POPULAR
Biogen to Present New Interim Data from Its Phase 1/2 Clinical...
May 1, 2019
CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR Technology Targeting...
February 13, 2019
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland,...
March 13, 2019
CASI Pharmaceuticals Announces Fourth Quarter And Full Year 2018 Financial Results...
March 29, 2019
Load more
HOT NEWS
Deals
Tilak Healthcare Announces Exclusive Partnership for Co-Promotion with Novartis France
Immuno-oncology
Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110...
Commercial
The Medicines Company Announces Pricing of Public Offering of Common Stock...
Deals
Merck Buys Peloton Therapeutics in $2.2 Billion Deal
